AN ACT CONCERNING CLINICAL TESTING FOR PULSE OXIMETERS.

SB 561 requires clinical testing for pulse oximeters to include patients with diverse racial and skin tone backgrounds. This bill directly affects medical device manufacturers and clinical testing organizations by mandating more inclusive testing protocols. The key provision amends state statutes to ensure pulse oximeter accuracy across all skin tones, addressing documented disparities in device performance. The policy change focuses on improving reliability for all patients during medical care without altering device functionality.